These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34665842)

  • 41. Factors that influence the satisfaction of people living with HIV with differentiated antiretroviral therapy delivery models in east Central Uganda: a cross-sectional study.
    Baleeta K; Muhwezi A; Tumwesigye N; Kintu BN; Riese S; Byonanebye D; Mbonye M; Mwehire D; Iriso R; Ayebazibwe B; Bailey L; Lopez D; McGough L; Etukoit M; Nantamu D; Nakitende L; Tibengana B; Wasswa J
    BMC Health Serv Res; 2023 Feb; 23(1):127. PubMed ID: 36750840
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Electronic Adherence Monitoring May Facilitate Intentional HIV Status Disclosure Among People Living with HIV in Rural Southwestern Uganda.
    Musiimenta A; Campbell JI; Tumuhimbise W; Burns B; Atukunda EC; Eyal N; Haberer JE
    AIDS Behav; 2021 Jul; 25(7):2131-2138. PubMed ID: 33389324
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Perceived Stigma and Fear of Unintended Disclosure are Barriers in Medication Adherence in Adolescents with Perinatal HIV in Botswana: A Qualitative Study.
    Madiba S; Josiah U
    Biomed Res Int; 2019; 2019():9623159. PubMed ID: 31886271
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adherence to antiretroviral therapy for HIV in sub-Saharan Africa and Asia: a comparative analysis of two regional cohorts.
    Bijker R; Jiamsakul A; Kityo C; Kiertiburanakul S; Siwale M; Phanuphak P; Akanmu S; Chaiwarith R; Wit FW; Sim BL; Boender TS; Ditangco R; Rinke De Wit TF; Sohn AH; Hamers RL
    J Int AIDS Soc; 2017 Mar; 20(1):21218. PubMed ID: 28362063
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessing the impact of HIV support groups on antiretroviral therapy adherence and viral suppression in the African cohort study.
    Mbah P; Iroezindu M; Esber AL; Dear N; Reed D; Adamu Y; Tiamiyu AB; Mohammed SS; Kibuuka H; Maswai J; Owuoth J; Bahemana E; Ake JA; Polyak CS; Crowell TA;
    BMC Infect Dis; 2021 Jul; 21(1):694. PubMed ID: 34281502
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HIV status disclosure and associated outcomes among pregnant women enrolled in antiretroviral therapy in Uganda: a mixed methods study.
    Naigino R; Makumbi F; Mukose A; Buregyeya E; Arinaitwe J; Musinguzi J; Wanyenze RK
    Reprod Health; 2017 Aug; 14(1):107. PubMed ID: 28854944
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of male partner involvement in ART retention and adherence in Malawi's Option B+ program.
    Wesevich A; Mtande T; Saidi F; Cromwell E; Tweya H; Hosseinipour MC; Hoffman I; Miller WC; Rosenberg NE
    AIDS Care; 2017 Nov; 29(11):1417-1425. PubMed ID: 28355926
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adherence clubs and decentralized medication delivery to support patient retention and sustained viral suppression in care: Results from a cluster-randomized evaluation of differentiated ART delivery models in South Africa.
    Fox MP; Pascoe S; Huber AN; Murphy J; Phokojoe M; Gorgens M; Rosen S; Wilson D; Pillay Y; Fraser-Hurt N
    PLoS Med; 2019 Jul; 16(7):e1002874. PubMed ID: 31335865
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Retention in care and adherence to HIV and AIDS treatment in Anambra State Nigeria.
    Umeokonkwo CD; Onoka CA; Agu PA; Ossai EN; Balogun MS; Ogbonnaya LU
    BMC Infect Dis; 2019 Jul; 19(1):654. PubMed ID: 31331280
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Uptake, engagement, and adherence to pre-exposure prophylaxis offered after population HIV testing in rural Kenya and Uganda: 72-week interim analysis of observational data from the SEARCH study.
    Koss CA; Charlebois ED; Ayieko J; Kwarisiima D; Kabami J; Balzer LB; Atukunda M; Mwangwa F; Peng J; Mwinike Y; Owaraganise A; Chamie G; Jain V; Sang N; Olilo W; Brown LB; Marquez C; Zhang K; Ruel TD; Camlin CS; Rooney JF; Black D; Clark TD; Gandhi M; Cohen CR; Bukusi EA; Petersen ML; Kamya MR; Havlir DV;
    Lancet HIV; 2020 Apr; 7(4):e249-e261. PubMed ID: 32087152
    [TBL] [Abstract][Full Text] [Related]  

  • 51. One-year adherence to clinic visits after highly active antiretroviral therapy: a predictor of clinical progress in HIV patients.
    Park WB; Choe PG; Kim SH; Jo JH; Bang JH; Kim HB; Kim NJ; Oh M; Choe KW
    J Intern Med; 2007 Mar; 261(3):268-75. PubMed ID: 17305649
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 'HIV is like a tsotsi. ARVs are your guns': associations between HIV-disclosure and adherence to antiretroviral treatment among adolescents in South Africa.
    Cluver LD; Hodes RJ; Toska E; Kidia KK; Orkin FM; Sherr L; Meinck F
    AIDS; 2015 Jun; 29 Suppl 1():S57-65. PubMed ID: 26049539
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The impact of community- versus clinic-based adherence clubs on loss from care and viral suppression for antiretroviral therapy patients: Findings from a pragmatic randomized controlled trial in South Africa.
    Hanrahan CF; Schwartz SR; Mudavanhu M; West NS; Mutunga L; Keyser V; Bassett J; Van Rie A
    PLoS Med; 2019 May; 16(5):e1002808. PubMed ID: 31112543
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Factors influencing social self-disclosure among adolescents living with HIV in Eastern Africa.
    Nöstlinger C; Bakeera-Kitaka S; Buyze J; Loos J; Buvé A
    AIDS Care; 2015; 27 Suppl 1(sup1):36-46. PubMed ID: 26616124
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of treatment outcomes for patients on first-line regimens in US President's Emergency Plan for AIDS Relief (PEPFAR) clinics in Uganda: predictors of virological and immunological response from RV288 analyses.
    Crawford KW; Wakabi S; Magala F; Kibuuka H; Liu M; Hamm TE
    HIV Med; 2015 Feb; 16(2):95-104. PubMed ID: 25124078
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rates and predictors of adherence and retention for antiretroviral therapy among HIV-positive adults in Enugu, Nigeria.
    Chime OH; Ndibuagu EO; Orji CJ
    Malawi Med J; 2019 Sep; 31(3):202-211. PubMed ID: 31839890
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antiretroviral therapy (ART) adherence and correlates to nonadherence among people on ART in Estonia.
    Uusküla A; Laisaar KT; Raag M; Šmidt J; Semjonova S; Kogan J; Amico KR; Sharma A; Dehovitz J
    AIDS Care; 2012; 24(12):1470-9. PubMed ID: 22533736
    [TBL] [Abstract][Full Text] [Related]  

  • 58. To tell or not to tell: negotiating disclosure for people living with HIV on antiretroviral treatment in a South African setting.
    Linda P
    SAHARA J; 2013 Jul; 10 Suppl 1():S17-27. PubMed ID: 23844799
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The association between HIV diagnosis disclosure and adherence to anti-retroviral therapy among adolescents living with HIV in Sub-Saharan Africa: A systematic review and meta-analysis.
    Mengesha MM; Teshome A; Ajema D; Tura AK; Hallström IK; Jerene D
    PLoS One; 2023; 18(5):e0285571. PubMed ID: 37167342
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Facilitators and barriers to uptake and adherence to lifelong antiretroviral therapy among HIV infected pregnant women in Uganda: a qualitative study.
    Buregyeya E; Naigino R; Mukose A; Makumbi F; Esiru G; Arinaitwe J; Musinguzi J; Wanyenze RK
    BMC Pregnancy Childbirth; 2017 Mar; 17(1):94. PubMed ID: 28320347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.